Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN study
A Falanga, A Santoro, R Labianca, F De Braud… - Thrombosis …, 2016 - Elsevier
The HYPERCAN is a prospective observational Italian multicentre study started in 2012,
structured in two main projects (ie Projects A and B) that involve both healthy subjects and
cancer patients. The HYPERCAN study aims to assess whether the occurrence of a
hypercoagulable state may be predictive of cancer diagnosis in healthy individuals, or may
be predictive of disease recurrence, clinical progression and thrombosis in cancer patients.
Project A involves two different large cohorts of subjects: The first cohort (Project A-1) …
structured in two main projects (ie Projects A and B) that involve both healthy subjects and
cancer patients. The HYPERCAN study aims to assess whether the occurrence of a
hypercoagulable state may be predictive of cancer diagnosis in healthy individuals, or may
be predictive of disease recurrence, clinical progression and thrombosis in cancer patients.
Project A involves two different large cohorts of subjects: The first cohort (Project A-1) …
